The drug substance particle size D90≤20μm was confirmed at the time of prescription development, and the Beagle bioavailability comparison study was conducted with the determined prescription and the drug substance, and the two are equivalent. <br>This limit is used for the particle size distribution of APIs used in the production of samples for clinical research.
正在翻译中..